Tuengerthal S, Spitz P
Rontgenblatter. 1978 Oct;31(10):592-5.
In a total of 157 patients, comparative infusion urography was conducted using different concentrations of the same infusion substance Joxitalmat (Telebrix). No fatal or severe side effects caused by the contrast medium were seen. Infusion of the 66% contrast medium solution C produced mild side effects in 9% of the patients, whereas 4% resp. 2% side effects occurred with the solutions A (39.7%) and B (36.6%). Hence, solutions A and B appear to be more appropriate for clinical diagnostics, the diagnostic value being approximately the same for all three solutions under investigation.
在总共157名患者中，使用相同的输注物质Joxitalmat（Telebrix）的不同浓度进行了对比性静脉肾盂造影。未观察到由造影剂引起的致命或严重副作用。66%造影剂溶液C的输注在9%的患者中产生了轻微副作用，而溶液A（39.7%）和B（36.6%）分别有4%和2%的副作用发生。因此，溶液A和B似乎更适合临床诊断，在所研究的三种溶液中，其诊断价值大致相同。
